Brain interfacing holds immense promise, both for restoring lost sensory, motor or cognitive function and for the treatment of neurological and neuropsychiatric disorders. The promise is driving a great deal of interest in brain interfacing technologies — from researchers, industry, investors, and the public — yet the clinical impact of these technologies is still limited. I’ll present my view of present state of brain interfacing and the key challenges and opportunities, as seen through the lens of my earlier research at UCSF and my more recent work in the startup world.

Co-hosted by the Center for Neuroengineering and Therapeutics (CNT) and Penn Health-Tech (PHT): contact littlab@seas.upenn.edu with any questions.